Move your research to market with ESCF.
Innovacorp’s president and CEO is now lending his business expertise to companies across the country, advising them on how they can enhance their operations and strategies.
The Globe and Mail asked Dan MacDonald to join its expert panel of business professionals from across Canada to tackle Business Incubator case studies. Once a month, the panel meets to discuss a real life small business venture and provide the entrepreneur with strategic advice. The audio and/or video discussion is then available via podcast on the Globe and Mail’s Report on Business website.
The staff and clients of Innovacorp welcome our newest client, Clearly Health.
Diabetes, cardiovascular disease, and cancer are among a group of chronic diseases that accounts for most deaths in all regions of the world. The world's elderly population, more prone to chronic disease, is growing. The result is a quiet epidemic of chronic illness that has gotten less attention than most conditions.
The staff and clients of Innovacorp welcome our newest client, Marsco Technologies.
An estimated 47,000 stove fires start in North American homes each year, often leading to injury or loss of life. Furthermore, an estimated $135 million in property damage is directly attributed to home fires each year, two-thirds of which are caused by kitchen stoves.
ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former senator, Michael Kirby, as the new board of directors chair. Michael Kirby succeeds the late Dr. Warrick Kimmins, who provided exemplary leadership during his tenure and was instrumental in spinning out IVT’s novel technology from Dalhousie University.
An intense five-month competition came to an end Tuesday evening as Innovacorp announced the provincial winner of the I-3 Technology Start-Up Competition. MorSwift Machines Inc. from Digby NS, was awarded a $100,000 seed equity investment from Innovacorp.
Check out some images from Innovacorp's I-3 Technology Start-Up Competition awards event - February 12, 2008.
See below for images from the awards event for Innovacorp's I-3 Technology Start-Up Competition - February 12, 2008.
All photos: (c) 2008 STEVEKAISERPHOTOGRAPHY.CA
EastMed Inc., a medical manufacturing company that caters specifically to women's health and wellness, welcomes two new members to its team: James Lodigiani, CEO, and Jeff Smith, chairman of the board.
“We are delighted to enhance our team with this caliber of talent,” said Dr. Scott Farrell, EastMed president and head of the urogynaecology division at the IWK Health Centre.
“Both Jim and Jeff bring tremendous experience in the successful introduction of health and wellness products to the marketplace. And they have expertise in leading start-up organizations.”
ImmunoVaccine Technologies Inc. (IVT) announced today that it has met with Health Canada’s regulatory affairs division, the Biologics and Genetic Therapies Directorate, to discuss requirements for a Phase I clinical trial application. For Phase I human clinical trials, IVT plans to combine novel antigens with its vaccine-enhancement technology, the VacciMax® platform.
ImmunoVaccine Technologies Inc. (IVT), announced today that it had signed licensing agreements for Pfizer Animal Health to apply IVT's novel VacciMax® vaccine platform to the potential development of future, particular livestock vaccines.
Although terms of the agreements were not disclosed, IVT will receive upfront signing fees, milestone and royalty payments.